Dr. Alexander B. Olawaiye
Claim this profileUniversity of Pittsburgh Cancer Institute (UPCI)
Studies Ovarian Cancer
Studies Ovarian Tumors
17 reported clinical trials
39 drugs studied
Area of expertise
1Ovarian Cancer
Stage IV
BRCA1 positive
Stage II
2Ovarian Tumors
Stage I
Stage IV
Stage II
Affiliated Hospitals
Clinical Trials Alexander B. Olawaiye is currently running
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
More about Alexander B. Olawaiye
Clinical Trial Related1 year of experience running clinical trials · Led 17 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Alexander B. Olawaiye has experience with
- Bevacizumab
- Olaparib
- Paclitaxel
- Carboplatin
- Cisplatin
- Letrozole
Breakdown of trials Alexander B. Olawaiye has run
Ovarian Cancer
Ovarian Tumors
Fallopian Tube Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alexander B. Olawaiye specialize in?
Alexander B. Olawaiye focuses on Ovarian Cancer and Ovarian Tumors. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are BRCA1 positive.
Is Alexander B. Olawaiye currently recruiting for clinical trials?
Yes, Alexander B. Olawaiye is currently recruiting for 8 clinical trials in Pittsburgh Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Alexander B. Olawaiye has studied deeply?
Yes, Alexander B. Olawaiye has studied treatments such as Bevacizumab, Olaparib, Paclitaxel.
What is the best way to schedule an appointment with Alexander B. Olawaiye?
Apply for one of the trials that Alexander B. Olawaiye is conducting.
What is the office address of Alexander B. Olawaiye?
The office of Alexander B. Olawaiye is located at: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania 15232 United States. This is the address for their practice at the University of Pittsburgh Cancer Institute (UPCI).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.